Matches in Nanopublications for { ?s ?p "[Treatment of human melanoma cells with a combination of recombinant fibroblast interferon (IFN-beta) and the protein kinase C (PKC) activator mezerein (MEZ) causes a rapid and irreversible suppression in growth and terminal cell differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_assertion description "[Treatment of human melanoma cells with a combination of recombinant fibroblast interferon (IFN-beta) and the protein kinase C (PKC) activator mezerein (MEZ) causes a rapid and irreversible suppression in growth and terminal cell differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617355.RAcP3KImJH6gaO1gjd2HhjuFVnVnAQ9DZNllfn2fkB3cs130_provenance.
- NP292073.RAd6MPuobgi47kuX0sFdBCQvuwXIbCMNB3UBHqTn-0pHA130_assertion description "[Treatment of human melanoma cells with a combination of recombinant fibroblast interferon (IFN-beta) and the protein kinase C (PKC) activator mezerein (MEZ) causes a rapid and irreversible suppression in growth and terminal cell differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292073.RAd6MPuobgi47kuX0sFdBCQvuwXIbCMNB3UBHqTn-0pHA130_provenance.